AI entity

Optellum

Company

All 1 tracked stories fall under one category: product-launch. Of the tracked stories, 1 of 1 also mention TGA, the most common co-covered peer. Each story carries 3 original sources on average, compared with 5.4 for the broader beat in this window.

Last mentioned: Feb 27, 2026

Entity pulse

Recent coverage · Optellum

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Optellum

All 1 tracked stories fall under one category: product-launch. Of the tracked stories, 1 of 1 also mention TGA, the most common co-covered peer. Each story carries 3 original sources on average, compared with 5.4 for the broader beat in this window. At 7, the average consequence score sits above the same-window beat average of 6.8. We currently track 1 AI story that mention Optellum, all published on February 27, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 53 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Optellum. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. TGA Approval

    Australian regulatory body approves the platform for clinical use in Australia.

  2. CE Mark

    Virtual Nodule Clinic receives CE marking for expansion into European markets.

  3. Series A Funding

    Company raises $14M to scale its AI platform globally.

  4. FDA Clearance

    Optellum receives first-of-its-kind FDA clearance for AI lung cancer decision support.

Stories mentioning Optellum 1

Product Launches Positive

Optellum Secures TGA Approval for AI Lung Cancer Diagnostic in Australia

Optellum has received regulatory clearance from Australia’s Therapeutic Goods Administration (TGA) for its AI-powered Virtual Nodule Clinic. This milestone allows the company to deploy its lung cancer early-detection technology across the Australian healthcare system, marking a major expansion into the Asia-Pacific market.

3 sources

Optellum is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.